US EditionA cautious culture cost Novo Nordisk its lead in the obesity drug race, former employees say
Summary by STAT
3 Articles
3 Articles
All
Left
Center
1
Right
Outgrowing your competition may not be that difficult, but outgrowing your own country is a different story. That's how you can define the story of the Danish pharmaceutical company Novo Nordisk. Thanks to its drugs Ozempic (primarily for diabetes) and Wegovy (for obesity), it managed to outgrow the economy of its own country,...
Novo Nordisk Loses Obesity Market Lead to Eli Lilly Amid Conservative Strategy
Novo Nordisk has reportedly lost its leading position i […] The post Novo Nordisk Loses Obesity Market Lead to Eli Lilly Amid Conservative Strategy first appeared on GeneOnline News. The post Novo Nordisk Loses Obesity Market Lead to Eli Lilly Amid Conservative Strategy appeared first on GeneOnline News.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
